Atracurium is a new, non-depolarizing muscle relaxant which rapidly breaks down in vivo and appears to require neither renal nor hepatic function for its elimination. As the commonly used non-depolarizing muscle relaxants carry the risk of prolonged effect when used in anephric patients, atracurium appears to have special promise in this situation. A preliminary account of the successful use of…
Neuromuscular blocking drugs (NMBDs) are now used less frequently in critically ill patients than they were 15 years ago, mainlyrnbecause of improved techniques of artificialrnventilation